Question: is this a 2) strong advice, 1) weak advice 0) no advice?

Considerations of both the 6-month clinical outcomes and the estimated 5-year cost-effectiveness suggest that EVLA should be considered as the treatment of choice for suitable patients.
user
This is a strong advice
assistant